Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06053515 · ClinicalTrials.gov registry record · NA

Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication

A NA study of Pregnancy and Postpartum Depression, sponsored by University of Maryland, College Park.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06053515: Recruiting NA study of Pregnancy and Postpartum Depression, sponsored by University of Maryland, College Park.

NCT06053515 is a NA study of Pregnancy and Postpartum Depression that is actively recruiting participants, run by University of Maryland, College Park. The registered enrollment target is 400 participants, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06053515, a NA study of Pregnancy and Postpartum Depression, is actively recruiting participants, sponsored by University of Maryland, College Park.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Rosie the Chatbot is an educational chatbot that moms can have on their computers or cellphones and will work by moms typing in their questions about pregnancy, health, infant milestones, and other variety of health related topics and receiving back a response immediately. Rosie only provides information from verified sources such as children's hospitals, health organizations and government agencies. Rosie does not ask moms to provide any personal information on her or her child, her chat is completely confidential, it works in English and Spanish and will be free.

Primary Outcome

The investigators will utilize the Patient Health Questionnaire (PHQ-9) Scale to measure maternal depression. This scale can range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). Higher scores indicate worse depression severity.

Interventions

  • BEHAVIORAL Rosie the Chatbot

Study Locations (1)

Maryland

  • University of Maryland - College Park

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-10-09
Est. Completion 2026-06-30
Phase NA

What NCT06053515 shows while recruiting

NCT06053515 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 871-participant average among 191 other Pregnancy trials with a reported enrollment target (54% lower).

The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Rosie the Chatbot is the first listed.

NCT06053515 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06053515 about?

NCT06053515 is a clinical study titled "Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication". Rosie the Chatbot is an educational chatbot that moms can have on their computers or cellphones and will work by moms typing in their questions about pregnancy, health, infant milestones, and other variety of health related topics and receiving back a response immediately. Rosie only provides inform...

What is the current status of trial NCT06053515?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-10-09. Estimated completion is 2026-06-30.

What conditions does trial NCT06053515 study?

This clinical trial studies the following conditions: Pregnancy, Postpartum Depression, Infant Development, Infant Conditions.

What interventions are being tested in trial NCT06053515?

The interventions under investigation include: Rosie the Chatbot (BEHAVIORAL).

Who is sponsoring clinical trial NCT06053515?

This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06053515 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06053515's enrollment target sits among peer trials

400 58th of 191 higher than 131 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06053515, the US trial registry maintained by the National Library of Medicine. NCT06053515 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.